Key Amarin Achievements News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Amarin Corporation plcFebruary 25, 2021 GMT
Record Revenue of $614.1 Million and $167.3 Million for Full Year and Fourth Quarter 2020 Despite COVID-19 Impact
Received Positive CHMP Opinion for VAZKEPA ®
in Europe and Continue to Advance Commercial Launch Plans for Europe
Management to Host Conference Call Today at 7:30 a.m. ET
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter and year ended December 31, 2020 and provided an update on company operations. ....

United States , Hong Kong , New Jersey , United Arab Emirates , Coll Cardiol , Clin Cardiol , Johnf Thero , European Commission , Exchange Commission , Exchange Commission Regulation , Hong Kong Department Of Health , Amarin Corporation , Chinese Society Of Cardiology , European Union , Chinese National Medical Products Administration , Journal Of The American College Cardiology , European Medicines Agency , Hikma Pharmaceuticals , Committee For Medicinal Products Human Use , Symphony Health , Record Revenue , Full Year , Fourth Quarter , Advance Commercial Launch Plans , Host Conference Call Today , Key Amarin Achievements ,